medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2005, Number 3

<< Back Next >>

Acta Med 2005; 3 (3)

Peripheral facial palsy. Report of 1,000 cases

Domínguez-Carrillo LG

Language: Spanish
References: 54
Page: 155-163
PDF size: 96.25 Kb.


ABSTRACT

Objective: Report the peripheral prosoplegia characteristics of 1,000 patients in prospective, observational and descriptive study. Material and methods: Facial palsy patients between 1 and 90 years old; observations: annual and monthly distribution; specialty of sending, sex and age distribution; important background; symptoms, anatomic zone of injury, evolution and complications. Results: annual presentation: mean and SD 40 ± 4.29; winter 56.6% and summer 28.7% predilections; familiar physician send 46% of cases; more frequently ages between 20 and 50 years old; diabetes mellitus was an important background in 23%, symptoms are related with motor affections; side distribution: left 52%, right 47.1% and 0.95 bilateral; by injured anatomic zone: zone I, 0.9%; II, 1.4%; III, 2.7%; IV, 12.9%; V, 21.8%; VI, 53.5%; VII, 4.9%; VIII, 1.9%; 34 diagnostic were observed, complete healing in 86% of cases between 2 and 8 weeks; complications: corneal ulcers, tearing, synkinesias and facial spasm. Conclusion: Bell’s palsy must be an exclusion diagnosis.


REFERENCES

  1. Zarranz JJ. Trastornos del nervio facial. En Neurología. 1era Ed. Madrid: Mosby/Doyma; 1995: 101-6.

  2. Gruner OC. A treatise on the canon of medicine of Avicenna incorporating a translation of the first book. London: Luzac, 1930.

  3. Pearce JM. Sir Charles Bell (1774-1842). J R Soc Med 1993; 86: 353-54.

  4. Bird TD, Nicolaus A. Friedreich’s description of peripheral facial nerve in 1798. J Neurol Neurosurg Psychiatry 1979; 42: 56-58.

  5. Vignos PJ, Watkins MP. The effect of exercise in muscular dystrophy. JAMA 1996; 197: 121-24.

  6. de Boulogne D. De L’électrisation localisée. Paris: Baillierie; 1855: 780-796.

  7. Bell C. On the nerves of the face, being a second paper on that subject. Philos Trans R Soc Lond B Biol Sci 1829; 119: 317-30. Reprinted in Medical Classics 1936; 1: 155-67.

  8. Bleicher JN, Hamiel BS, Gengler JS. A survey of facial paralysis: etiology and incidence. Ear Nose Throat J 1996; 75: 355-8.

  9. Spruance SL. Bell palsy and herpes simplex virus. Ann Intern Med 1994; 120: 1045-6.

  10. Petruzzelli G, Hirsch B. Bell’s palsy: a diagnosis of exclusion. Postgrad Med 1991; 90: 115-23.

  11. Jackson CG, Glassocock ME, Hughes G, Sismanis A. Facial paralysis of neoplastic origin: diagnosis and management. Laryngoscope 1980; 90: 1581-95.

  12. Arriaga MA, Chen DA, Fucushima T. Individualizing hearing preservation in acoustic neuroma surgery. Laryngoscope 1997; 107: 1043-7.

  13. Hoffer E. Annual meeting of the facial nerve study group. Arch Otolaryngol Head Neck Surg 1995; 121: 240.

  14. Furuta Y, Ohtani F, Mesuda Y, Fukuda S, Inuyama Y. Early diagnosis of zoster herpete and antiviral therapy for the treatment of facial palsy. Neurology 2000; 55: 708.

  15. Smith BE. Neuropatía craneal en la diabetes mellitus. En: Dyck PJ, Thomas PK. Neuropatía diabética. 2da Edición. México, D.F.: McGraw-Hill Interamericana; 2000: 485-96.

  16. Albisetti M, Schaer G, Good M, Boltshauser E, Nadal D. Diagnostic value of cerebro-spinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis. Neurology 1997; 49: 817.

  17. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001; 56: 1104.

  18. Chutorian AM, Gold AP, Braun CW. Benign intracranial hypertension and Bell’s palsy. New Engl J Med 1977; 296: 1214-15.

  19. May M, Schaitkin BM. The facial nerve. New York: Thieme, 2000: 213-230.

  20. Domínguez CL. Zonas anatómicas de lesión en parálisis facial periférica y su relación etiológica, experiencia de 780 casos. Cir Ciruj 2002; 70: 239-45.

  21. Kendall HO, Kendall FP, Wadsworth GE. Músculos, pruebas y funciones. 1ª ed. Barcelona: Jims edit. 1974: 243-59.

  22. House JW, Brackmann DE. Facial nerve grading system. Otolaringol Head Neck Surg 1995; 93: 146-7.

  23. Hollwich F. Oftalmología. 8ª ed. Barcelona: Salvat edit. 1978: 45.

  24. Surós BJ, Surós BA. Semiología médica y técnica exploratoria. 7ª ed. Barcelona: Salvat edit. 1987: 699.

  25. Van Swearingen JM, Brach JS. The facial disability index: reliability and validity of a disease specific instrument. Phys Ther 1996; 76: 1288-300.

  26. Ross BG, Fredet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg 1996; 114: 380-6.

  27. May M, O’Hara K. Imaging studies: Diagnostic role and clinicopathological correlations. In: May M, Schaitkin BM. The Facial Nerve. New York: Thieme, 2000: 231-274.

  28. 28- Tilden DH, DeMasters K, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 1998; 339: 1553.

  29. Sweeney CJ, Gilden DH. Ramsay hunt syndrome. J Neurol Neurosurg Psychiatry 2001; 71: 149-54.

  30. Murakami S, Honda N, Mizobuchi M, Nakashiro Y, Hato N, Gyo K. Rapid diagnosis of varicella zoster virus infection in acute facial palsy. Neurology 1998; 51: 1202.

  31. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Internal Med 1996; 124: 27-30.

  32. Kesler A, Vainstein G, Gadoth N. Melkersson-Rosenthal syndrome treated by methyl- prednisolone. Neurology 1998; 51: 1440.

  33. Jorba SB, Peñaloza GM et al. Parálisis facial. Rev Hosp Gral Dr. Gea González 2001; 4: 21-26.

  34. Pecket P, Schattner A. Concurrent Bell’s palsy and diabetes mellitus: a diabetic mononeuropathy? J Neurol Neurosurg Psychiatry 1997; 65: 98-106.

  35. Tien R, Dillon WP, Jackler RK. Contrast-enhanced MR imaging of the facial nerve in 11 patients with Bell’s palsy. Am J Roentgen 1990; 155: 573-79.

  36. Mustard RA, Anderson W. Malignant tumors of the parotid. Ann Surg 1964; 159: 291-304.

  37. Royal MA. The use of botulinum toxins in the management of pain and headache. Pain Practice 2001; 1: 215-235.

  38. Steere AC. Medical Progress: Lyme Disease. N Engl J Med 2001; 345: 115-125.

  39. Hassan NF, Siazon CL, Bennett M, Armesto DG. Progressive neurosarcoidosis. Arch Phys Med Rehabil 1997; 78: 1382-3.

  40. Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994; 44: 1198-1203.

  41. Urban PP, Forst T, Lenfers M, Koehler J, Connerman BJ, Beyer J. Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitus. Electromyogr Clin Neurophysiol 1999; 39: 267-72.

  42. Pastuzac AL, Shuller L, Speck CE, Coelho KE. Use of misoprostol during pregnancy and Möbius syndrome in infants.

  43. Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T. Use of the inactived intranasal influenza vaccine and the risk of Bell’s palsy. N Engl J Med 2004; 350: 896-903.

  44. Syed NA, Delgado A, Sandbrink F, Schulman AE, Hallet M, Floeter MK. Blink reflex recovery in facial weakness. Neurology 1999; 52: 834-6.

  45. Devrise PP, Shumacher T, Scheide A, de Joung R, Houtkooper JM. Incidence, prognosis and recovery of Bell’s palsy. A survey of about 1,000 patients, 1974-1982. Clin Otolaryngol 1990; 15: 15-27.

  46. González CL, Sánchez OAO, Pérez BM. Estandarización de la onda F del nervio facial y su valor pronóstico en la parálisis facial. Rev Mex Med Fis Rehab 2001; 13: 113-15.

  47. Sucar LE, Vargas A, Hidalgo JL, Martínez A, Leder RS, Hernández J, Bach y Rita P, Paredes O. A prototype for automatic image analysis to quanta rehabilitation of chronical facial palsy. Rev Mex Ing Biomed 2004; 25: 109-13.

  48. Aramide M, Koelman JH, Devriese PP, Speelman JD, Ongerboer BW. Thixotropy of levator palpebrae as cause of lagophtalmos after peripheral facial nerve palsy. J Neurol Neurosurg Psychiatry 2000; 72: 665-67.

  49. Colosimo C, Chinese M, Romano S, Vanacore EK, Tan LL. Is hypertension associated with hemifacial spasm? Neurology 2003; 61: 587-8.

  50. Íñigo MF y col. Mejoría funcional y estética de la parálisis facial después de injertos nerviosos cruzados y procedimientos complementarios. Cir Plast 2003; 13(3): 108-114.

  51. Boroojerdi B, Ferbert A, Schwarz M, Herath H, Noth J. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 1997; 65: 111-14.

  52. Ho SL et al. A case-controlled MRI/MRA study of neurovascular contact in hemifacial spasm. Neurology 1999; 53: 2132.

  53. Revuelta GR, Vales HL, Arvizu SE, Hinojosa GR, Reyes MI. Descompresión microvascular para el espasmo hemifacial, experiencia de 10 años. Cir Ciruj 2003; 71: 5-10.

  54. Grogan PM, Gronseth GS. Practice parameter: Steroids, acyclovir, and surgery for Bell’s palsy: an evidence based review. Report of the Quality Standar Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 830-31.




2020     |     www.medigraphic.com